Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report released on Monday. The firm set a “sell” rating on the stock.

Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.

Streamline Health Solutions Price Performance

Shares of STRM opened at $2.31 on Monday. The stock has a market cap of $9.75 million, a P/E ratio of -0.47 and a beta of 1.64. Streamline Health Solutions has a 1 year low of $1.85 and a 1 year high of $9.75. The stock’s 50-day moving average price is $2.85 and its two-hundred day moving average price is $5.44. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66.

Streamline Health Solutions (NASDAQ:STRM) last released its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The firm had revenue of $4.48 million for the quarter.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.